Literature DB >> 6671850

Computed axial tomography and Disulphine Blue in the evaluation of osteonecrosis of the femoral head.

P P Casteleyn, H De Boeck, F Handelberg, P Opdecam.   

Abstract

Precise evaluation of bone loss and bone viability is necessary in order to select the most appropriate operation for patients with osteonecrosis of the femoral head. Bone destruction, and its exact location, can be assessed by computed axial tomography. The viability of remaining bone can be observed at operation by systemic vital staining with Disulphine Blue.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6671850     DOI： 10.1007/bf00269498

Source DB:  PubMed          Journal:  Int Orthop        ISSN： 0341-2695            Impact factor:   3.075


  5 in total

1.  [Palliative operations in developed osteonecrosis].

Authors:  P Ficat
Journal:  Rev Chir Orthop Reparatrice Appar Mot       Date:  1973

2.  [Therapeutic results of drill biopsy in primary osteonecrosis of the femoral head (100 cases)].

Authors:  P Ficat; J Arlet; R Vidal; A Ricci; J C Fournial
Journal:  Rev Rhum Mal Osteoartic       Date:  1971-04

3.  Mechanical strength of the femur following resurfacing and conventional total hip replacement procedures.

Authors:  K L Markolf; H C Amstutz
Journal:  Clin Orthop Relat Res       Date:  1980 Mar-Apr       Impact factor: 4.176

4.  Cemented double cup arthroplasty of the hip: a 5 year experience with the ICLH prosthesis.

Authors:  M A Freeman; H U Cameron; G C Brown
Journal:  Clin Orthop Relat Res       Date:  1978 Jul-Aug       Impact factor: 4.176

5.  [The use of sulphan blue dye during surgical procedures for bone infection].

Authors:  G Jenny; I Kempf; J H Jaeger; S Betar; G Gebauer
Journal:  Rev Chir Orthop Reparatrice Appar Mot       Date:  1977-09
  5 in total
  1 in total

1.  Computed tomography with multiplanar reformation and three-dimensional image reconstruction in the preoperative evaluation of adult hip disease.

Authors:  D J Sartoris; D Resnick; D Bielecki; D Gershuni; M Meyers
Journal:  Int Orthop       Date:  1988       Impact factor: 3.075
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.